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Executive Summary 
The 2008 MDPH Massachusetts Arbovirus Surveillance and Response plan provides surveillance and 
phased response guidance for both West Nile virus (WNV) and eastern equine encephalitis virus (EEE).  
The year 2007 was witness to continued West Nile virus activity across the state. In the past five years 
there have thirty-four cases of WNV infection reported in Massachusetts and thirteen human cases of 
EEE resulting in six deaths. This plan reflects a comprehensive review of surveillance activities, mosquito 
control efforts, public information and risk communication related to arbovirus control in Massachusetts.  
The purpose of the plan is to provide guidance on operational aspects of surveillance and response by 
state and local agencies responsible for the prevention of mosquito-borne disease in the 2008 season. 
The Department of Public Health will continue to seek advice from its partners and collaborators and 
modify the plan, as appropriate. This document is open to continual review and evaluation. Information is 
provided to guide planning and actions to reduce the risk of human disease from EEE virus and WNV.   
Key objectives contained in this plan provide for:  
• the monitoring of trends in EEE virus and WNV activity in Massachusetts;  
• the timely collection and dissemination of information on the distribution and intensity of WNV and 
EEE virus in the environment;  
• the laboratory diagnosis of WNV and EEE cases in humans, horses and other mammals;  
• the effective communication, advice and support of activities that may reduce risk of infection. 
This document provides information about EEE and WNV disease and program goals, and specific 
guidelines for mosquito, avian, equine and human surveillance.  Additionally, this document provides 
guidance for the dissemination of information, including routine information; media advisories of positive 
EEE virus and WNV findings in birds and mosquitoes, as well as public health alerts related to positive 
EEE and WNV human cases.              
This plan describes MDPH’s public outreach efforts to provide helpful and accurate communications to 
Massachusetts’ citizens about their risk from arboviral diseases and specific actions that individuals and 
communities can take to reduce this risk. 
Recommendations regarding the WNV phased response plan appear in Table 1 and incorporate 
components presented in the “Massachusetts Surveillance and Response Plan for Mosquito-Borne 
Disease”, May 2004; as well as those presented in the Centers for Disease Control and Prevention (CDC) 
document, “Epidemic/Epizootic West Nile Virus in the United States: Guidelines for Surveillance 
Prevention, and Control”, 3rd Revision, 2003.  Recommendations regarding the EEE virus phased 
response plan appear in Table 2 and incorporate information provided in the MDPH document, “Vector 
Control Plan to Prevent Eastern (Equine) Encephalitis”, 1991, as well as analyses of additional 
surveillance data collected in Massachusetts since that time. 
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I.   INTRODUCTION 
The Massachusetts Department of Public Health (MDPH), in collaboration with regional mosquito control 
projects (MCPs), conducts surveillance for mosquito-borne viruses that pose a risk to human health. The 
Massachusetts Arbovirus Surveillance Program (MASP) 
• tests mosquitoes, birds, veterinary specimens from horses and other mammals, and humans for 
evidence of infection; identifies areas of disease risk;  
• provides information to guide decision-making to reduce the risk of disease;  
• informs the public of where and when there is an increased risk of infection.  
The MASP currently focuses on West Nile (WNV) and eastern equine encephalitis (EEE) viruses, which 
are found in the local environment and are capable of causing serious illness and death in human, 
horses and other mammals. 
The 2008 Massachusetts Surveillance and Response Plan for mosquito-borne diseases is based on a 
comprehensive plan initially developed for WNV in 2001 in collaboration with local health agencies, other 
state agencies, academic institutions, the Centers for Disease Control and Prevention (CDC), and 
interested groups and individuals. It incorporates components of the state’s EEE surveillance activities, 
which began in the 1950’s and have continued since that time. The Massachusetts Arbovirus Surveillance 
Program (MASP) began monitoring for WNV following a 1999 outbreak of human WNV disease in the 
New York City area, the first known occurrence of this disease in North America. WNV was identified in 
birds and mosquitoes in Massachusetts during the summer of 2000 and has been found during each 
consecutive season.  
 
The updated 2008 plan is the result of analyses of surveillance data collected in Massachusetts and the 
United States. In addition, in order to manage the complexity of the human disease risk posed by these 
viruses, MDPH convened four workgroups that advised MDPH and promoted collaborative efforts by 
multiple agencies and interest groups. The purpose of the plan is to provide guidance on operational 
aspects of surveillance and response by the state and local agencies with responsibilities for the 
prevention of mosquito-borne disease.  MDPH will continue to seek advice from its partners and 
collaborators and modify the plan, as appropriate. This document is open to continual review and 
evaluation with changes made when there is opportunity for improvement.  
 
 
II. DISEASE BACKGROUND 
 
The two principal mosquito-borne viruses (also known as arboviruses, for arthropod-borne viruses) 
recognized in Massachusetts and known to cause human and animal disease are eastern equine 
encephalitis virus with the first human cases identified in both the United States and Massachusetts in 
1938, and West Nile virus, with the first human case identified in the United States in 1999, and in 
Massachusetts in 2001.   
 
 
 
 
Eastern Equine Encephalitis Virus 
 
 
Background 
Eastern equine encephalitis is a serious disease with 30-50% mortality and lifelong neurological disability 
among many survivors, which occurs sporadically in Massachusetts.  The first symptoms of EEE are 
fever (often 103º to106ºF), stiff neck, headache, and lack of energy.  These symptoms show up three to 
ten days after a bite from an infected mosquito. Inflammation and swelling of the brain, called 
encephalitis, is the most dangerous and frequent serious complication.  The disease gets worse quickly 
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and some patients may go into coma within a week. There is no treatment for EEE.  In Massachusetts, 
approximately half of the people identified with EEE have died from the infection.  People who survive this 
disease will often be permanently disabled. Few people recover completely.  
 
 
 
Historically, clusters of human cases have occurred in cycles lasting 2-3 years, with a hiatus of 10-20 
years between outbreaks. In the years between outbreaks, isolated cases may occur.  Outbreaks of 
human EEE disease in Massachusetts occurred in 1938-39 (35 cases, 25 deaths), 1955-56 (16 cases, 9 
deaths), 1972-74 (6 cases, 4 deaths), 1982-84 (10 cases, 3 deaths), 1990-92 (4 cases, 1 death), 2004-06 
(13 cases, 6 deaths).  
 
Massachusetts Eastern Equine Encephalitis Experience 
Year(s) Human EEE Cases Human EEE Deaths 
1938-39 35 25 
1955-56 16 9 
1972-74 6 4 
1982-84 10 3 
1990-92 4 1 
2004-06 13 6 
 
 
The Massachusetts Department of Public Health, with CDC funding, initiated a field surveillance program 
in 1957; following a 1955-56 outbreak of EEE. The purpose of the program was to gather data to guide 
prevention and risk reduction of this disease. 
 
 
Risk Factors for Disease Transmission 
Eastern equine encephalitis virus is an alphavirus enzootic in some passerine bird species found in fresh-
water swamp habitats. The virus is transmitted among wild birds in these areas primarily by Culiseta 
melanura, a mosquito species that feeds predominantly on birds. This mosquito-borne virus has a cycle 
of natural infection among bird populations with occasional ‘‘incidental” symptomatic infections of 
humans, horses, llamas, alpacas, emus and ostriches.  The prevalence of infection among birds is related 
to the prevalence in bird-feeding mosquitoes.  When infections become more prevalent among birds, 
infection rates may also rise in mosquitoes that feed indiscriminately on birds and other animals.  Thus, 
infection within these bridge vector mosquitoes seems to enhance the risk of infection to people.  
 
Outbreaks involving two or more human infections associated temporally and spatially; occur with the 
convergence of several factors. A major factor that affects the risk of disease in humans is the prevalence 
of immunity to EEE virus in the birds that serve as the enzootic reservoir of the virus. EEE virus infection 
in passerine birds usually results in a mild infection. Following infection, birds become immune to the virus 
and will not harbor it. Following a year of increased viral transmission, the prevalence of EEE immunity in 
birds increases and in subsequent years, the virus may not be able to spread rapidly among these 
reservoir hosts due to the establishment of ‘herd immunity’.  Thus, elevated levels of herd immunity in 
birds reduce the amplification of EEE virus in the bird-mosquito-bird cycle, which in turn reduces the 
chance of incidental infections in humans.  
 
The risk of infection in humans is a function of exposure to infected human-biting mosquitoes. Certain 
kinds of mosquitoes are highly selective as to the kind of host they will seek and feed upon.  Culiseta 
melanura (Cs. melanura) mosquitoes feed primarily on birds and are recognized as the predominant 
vector of EEE virus transmission between the passerine birds that are the reservoir of the virus. Thus, the 
intensity of enzootic EEE virus transmission correlates with the abundance of this enzootic vector. If the 
herd immunity level against EEE virus of these birds is high, (i.e. few susceptible birds) due to several 
years of prior exposure, then there is little opportunity for the virus to perpetuate or amplify within the bird 
population. When herd immunity is low and there are many susceptible birds; EEE virus infections can 
spread more rapidly and more widely among the birds. This condition may enhance the potential for 
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transfer of EEE virus to humans by a ‘bridge vector’ mosquito, i.e., a species that is indiscriminant and will 
feed on birds or humans, such as Coquillettidia perturbans, Ochlerotatus canadensis, Aedes vexans and 
Culex species. 
 
The risk of EEE virus infection in humans varies by geographical area in Massachusetts, as well as in the 
United States. EEE is more prevalent in areas that support dense populations of passerine birds and 
have favorable breeding conditions for the enzootic vector. In Massachusetts, these areas consist mainly 
of large wetlands containing mature white cedar and red maple swamps that are more common in 
southeastern Massachusetts. The majority of EEE cases have occurred in Norfolk, Bristol, and Plymouth 
counties with some cases also occurring in Middlesex County, rarely in Essex County and very rarely in 
Worcester County or further west. Historically, Cape Cod and the Islands of Martha’s Vineyard and 
Nantucket have not had human cases of EEE. 
 
Other major factors that affect the risk of EEE virus infections for humans are the abundance of specific 
kinds of mosquitoes at critical periods of the transmission season, groundwater levels and the timing of 
rainfall and flooding during the mosquito season.  Participation in outdoor activities increases the risk of 
exposure while the use of personal protective measures (e.g., avoidance of mosquitoes, use of repellent) 
helps to reduce the risk of exposure.  
 
Long-term weather patterns during the fall and winter that include high ground water levels and snow 
cover may enhance survival of Cs. melanura larval populations. The abundance of these larval 
populations may serve as an early indicator of the potential for human disease later in the year. 
Multiple factors affect the development, survival, and abundance of mosquitoes. It is not currently 
possible to predict either the abundance of mosquitoes or the risks of encountering an infected vector 
later in the season. The best control approach to reduce these vectors must consider multiple factors. 
One approach calls for beginning integrated pest management (IPM) control activities early in the season 
and targeting both the enzootic and human biting vector species.  
 
 
 
West Nile Virus 
Background                                                                                                                                                                                                       
West Nile Virus (WNV) first appeared in the United States in 1999. Since its initial outbreak in New York 
City, the virus has spread across the US from East to West. WNV infection may be asymptomatic in some 
people, but it leads to morbidity and mortality in others.  WNV causes sporadic disease of humans, and 
occasionally results in significant outbreaks. Nationally, over 3600 human cases of WNV neuroinvasive 
disease (West Nile meningitis and West Nile encephalitis) and WNV fever were reported to the CDC in 
2007.   
The majority of people who are infected with WNV (approximately 80%) will have no symptoms. A 
smaller number of people who become infected (~ 20%) will have symptoms such as fever, 
headache, body aches, nausea, vomiting, and sometimes swollen lymph glands.  They may also 
develop a skin rash on the chest, stomach and back. Less than 1% of people infected with WNV will 
develop severe illness, including encephalitis or meningitis.  The symptoms of severe illness can 
include high fever, headache, neck stiffness, stupor, disorientation, coma, tremors, convulsions, 
muscle weakness, vision loss, numbness and paralysis.  Persons older than 50 years of age have a 
higher risk of developing severe illness. In Massachusetts, there were six fatal WNV human cases 
identified between 2001-2007, all in individuals eighty years of age or older. 
                                                                                                                                                                                                                        
Following the identification of WNV in birds and mosquitoes in Massachusetts during the summer of 
2000, MDPH arranged meetings between local, state and federal officials, academicians and the public to 
develop recommendations to improve and strengthen key aspects of the state plan for mosquito-borne 
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virus surveillance and prevention of mosquito-borne disease. Four workgroups addressed the issues of 
surveillance, risk reduction interventions, pesticide toxicity and communication.   
 
Risk Factors for Disease Transmission 
West Nile (WN) virus is amplified by a cycle of continuous transmission between mosquito vectors and 
bird reservoir hosts. Infectious mosquitoes carry virus particles and infect susceptible bird species. WNV 
infection is often fatal in some species of birds, particularly American crows and blue jays (corvids).  
Confirmation of WNV in dead birds provides sentinel information useful for assessing risk of human WNV 
infections.  
The principal mosquito vector for West Nile virus on the East coast is the Culex species. These species 
may be abundant in urban areas, breeding easily in artificial containers such as birdbaths, discarded tires, 
buckets, clogged gutters, and other standing water sources. Culex pipiens feeds mainly on birds and 
occasionally on mammals. It will bite humans, typically from dusk into the evening. Culex restuans feeds 
almost primarily on birds but has been known to bite humans on occasion. Brackish and freshwater 
wetlands are the preferred habitat for Culex salinarius which feeds on birds, mammals, and amphibians 
and is well known for biting humans. Ochlerotatus japonicus may be involved in the transmission of both 
WNV and EEE virus. Natural and artificial containers such as tires, catch basins, and rock pools are the 
preferred larval habitat of this mosquito. It feeds mainly on mammals and is a fierce human biter.  
Activity of the West Nile virus zoonotic cycle varies from year to year.  When a large number of infected 
birds and a high rate of infected mosquitoes are found in a relatively small geographic area, the risk of 
transmission of virus to humans will increase.  
 A summary of current and historical surveillance information for EEE virus and WNV in Massachusetts is 
available at www.mass.gov/dph. 
 
III. PROGRAM GOALS 
Timely and accurate information provided by the MDPH based on surveillance information can be used to 
provide an indication of the level of risk of human disease from WNV and EEE. Based on this surveillance 
information, plans and actions to reduce risk can be developed and implemented when needed.  
Specific Program Priorities 
1. Test mosquitoes, birds, horses, humans and other animals to identify EEE virus and WNV 
infections. 
2. Track trends in incidence and prevalence of EEE virus and WNV infections by geographic area. 
3. Estimate viral infection rates in birds and mosquitoes. 
4. Stratify risk o geographic areas as a function of their relative risk of human disease.  
5. Conduct surveillance for human and equine disease. 
6. Educate human and animal medical practitioners on the appropriate procedures for detecting and 
identifying infections and disease caused by mosquito-borne viruses. 
7. Recommend measures to reduce virus transmission and disease risk. 
8. Provide information to the public on mosquito-borne diseases and disease risk, and on common-
sense precautions to reduce the risk of infection.  
9. Participate in the national Arbovirus surveillance network coordinated by the CDC. 
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Roles 
 
1. Massachusetts Department of Public Health (MDPH)  
The central purpose of the Massachusetts Arbovirus Surveillance Program (MASP) is to provide 
information that will guide planning and actions to reduce the risk of human disease from EEE virus and 
WNV. To achieve this, the main objectives are to monitor trends in EEE virus and WNV in Massachusetts; 
provide timely information on the distribution and intensity of WNV and EEE virus in the environment; 
perform laboratory diagnosis of WNV and EEE cases in humans, horses and other mammals; 
communicate effectively with officials and the public; provide guidelines, advice and support on activities 
that effectively reduce risk of disease; and provide information on the safety, anticipated benefits and 
potential adverse effects of proposed prevention interventions. 
 
MDPH works cooperatively with the Massachusetts State Reclamation and Mosquito Control Board 
(SRMCB) and with regional mosquito control projects to identify and support the use of safe and effective 
mosquito control measures based on integrated pest management (IPM) principles. The application of 
pesticides as a means to reduce human risk is one of several methods/strategies to attain this goal. 
  
 
2. State Reclamation and Mosquito Control Board (SRMCB) 
 
The State Reclamation and Mosquito Control Board (SRMCB) oversees mosquito control in the 
Commonwealth of Massachusetts. The SRMCB consists of three (3) members representing the 
Department of Agricultural Resources (DAR), Department of Conservation and Recreation (DCR), and 
Department of Environmental Protection (DEP).  Additionally, the SRMCB advises its respective state 
agency Commissioners on actions to reduce mosquito populations based on MDPH findings and 
characterization of risk.   
 
The SRMCB ‘Operational Response Plan to Reduce the Risk of Mosquito-Borne Disease in 
Massachusetts’ addresses the issues related to the operational aspect of adult mosquito surveillance and 
control to prevent and/or reduce the risk of mosquito-borne diseases.   
 
In 2006, the SRMCB created an SRMCB Mosquito Advisory Group (MAG). The MAG provides 
independent scientific advice to the SRMCB to assist them in evaluating and assessing data from both 
DPH and mosquito control projects 
 
 
3. Mosquito Control Projects (MCP) 
There are nine (9) organized mosquito control projects or districts located throughout Massachusetts.  All 
of the mosquito control activities of these organized agencies are performed under the aegis of the State 
Reclamation and Mosquito Control Board (SRMCB).  Mosquito Control Projects collaborate with local 
boards of health in their jurisdictions to control mosquitoes. These locally authorized efforts employ a 
variety of targeted activities for source reduction, larviciding and adulticiding that are in compliance with 
the SRMCB Operational Response plan.  
 
 
 
 
IV. SURVEILLANCE  
 
A. Mosquito Surveillance for West Nile Virus (WNV) and Eastern Equine Encephalitis (EEE) Virus 
 
Surveillance of mosquitoes for arboviruses is one of the core functions of the MASP. Monitoring 
mosquitoes for the presence of virus provides a direct estimate of risk to humans. Massachusetts has a 
long-term field surveillance program that was initiated in 1957 for EEE virus and was modified in 2000 to 
include WNV surveillance. The extensive experience in Massachusetts with surveillance for mosquito-
borne disease provides expertise and capacity to guide risk reduction efforts. The MASP uses a 
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comprehensive and flexible strategy that modifies certain surveillance activities in response to trends in 
disease risk.  
 
On an ongoing basis, MASP will continue to monitor national and regional surveillance data and current 
scientific literature to assess risk of newly emerging arboviruses in Massachusetts. In addition, defined 
subsets of mosquito pools will be evaluated by MDPH for the presence of new or emerging viruses 
 
 
1. Fixed and Long-Term Trap Sites:  MASP will collect mosquitoes from areas with activity during the 
previous year, and from long-term trap sites maintained in the EEE virus high-risk areas of southeastern 
and eastern Massachusetts (Figure 1). Trapping of gravid mosquitoes for testing of WNV is conducted 
both by mosquito control projects and MDPH staff at various locations throughout the state during the 
arbovirus season. At the State Laboratory Institute (SLI), samples (pools of 1- 50 specimens) of trapped 
mosquito collections are assayed for WNV and EEE virus. Test results from routine mosquito collections 
are available within 24-48 hours. Fixed and long-term trap sites provide the best available baseline 
information for detecting trends in mosquito abundance and virus prevalence and for estimating the 
relative risk of human infection from EEE virus and WNV. MDPH will monitor larvae from select sites in 
late fall and early spring to determine end-season and pre-season larval abundance. Monitoring of larval 
abundance from these sites will continue on a weekly basis during the arbovirus season.  
2. Supplemental Trap Sites:  When EEE virus or WNV activity, or increased WNV bird deaths, 
are detected in an area, additional trap sites and/or trap types will be used to obtain more 
information regarding the intensity of virus activity in mosquitoes. The following risk indicators 
may result in the implementation of more intensive mosquito trapping: 1) virus isolations in 
mosquitoes; 2) increasing or significant numbers of bird deaths associated with WNV; 3) 
emergence of large numbers of human-biting mosquitoes in an area with a high rate of virus 
activity and 4) human or equine cases 
3. Mosquito Control Project Trap Sites:  Massachusetts mosquito control projects (MCP’s), are 
organized under the State Reclamation and Mosquito Control Board (SRMCB), located within 
Department of Agricultural Resources. The SRMCB is composed of three members; representing 
the Department of Agricultural Resources; the Department of Environmental Protection; and the 
Department of Conservation and Recreation. MCP’s and the SRMCB communicate 
collaboratively with the MASP. The mosquito control projects employ comprehensive, integrated 
mosquito management (IMM) programs based on integrated pest management (IPM) principles.  
The IMM program uses a variety of available control strategies to impact mosquito abundance. Monitoring 
mosquito abundance is accomplished through various surveillance methods including but not limited to 
larval dip counts, the use of light/ CO2 baited traps and gravid traps.  
 
 
 
B.  Avian Surveillance: West Nile Virus (WNV) and Eastern Equine Encephalitis Virus (EEE virus) 
1. Dead Bird Reports: Because WNV causes death in certain species of birds, and the mortality 
rate from infection for the American crow is high, we expect that dead birds may be the first 
warning of WNV activity in an area. The association between corvid deaths and WNV activity is 
well established. The MASP tracks dead bird reports provided by local and state officials, and 
from the public. MASP will request that crows and blue jays, representing the species most likely 
to experience mortality due to WNV, be submitted for testing, and will provide a pickup service for 
designated regional repositories to assist local communities in the transport of specimens to 
MDPH.  Most kinds of birds that are infected with EEE virus survive the viremia, making dead bird 
EEE virus monitoring impractical. Thus, MASP does not utilize dead bird reports for EEE virus 
monitoring. 
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MASP will record and analyze dead bird reports, which will be used to identify areas for intensified 
surveillance of WNV activity including bird testing, and mosquito trapping. Reports of dead birds are taken 
via a toll-free telephone number at MDPH (866 MASS WNV, or 866-627-7968), which may be used by 
local officials and the public. At the time of the report, information on the location and type of bird will be 
collected and entered into a surveillance database. The caller will be informed if the reported bird is to be 
tested, and arrangements will made for pickup and delivery if needed. Otherwise the caller will be 
informed of proper disposal procedures for the dead bird. 
These reports are summarized daily and provided to local health agents, the public and the media 
via a public website (www.mass.gov/dph.)   
 
2.  Laboratory Testing of Dead Wild Birds for West Nile Virus (WNV) and Eastern Equine 
Encephalitis Virus (EEE virus): The MASP will collect and test dead birds, primarily crows and 
blue jays, for WNV. Routine testing is generally completed within 24-48 hours. Confirmatory 
testing, when necessary, may take approximately four working days. After WNV infection of a bird 
population has been established by confirmation of two WNV avian specimens within a focal 
area, further routine bird testing will discontinued in that area. Boston and areas defined as 
‘Boston neighborhoods’ are considered to be one geographic focal area.  Therefore, avian testing 
will continue until two positives are identified within this focal area. Following the finding of two 
WNV specimens, and in the presence of continued bird deaths, a limited sample of dead birds 
may be tested to confirm that additional bird deaths are the result of WNV infection. In addition, 
ongoing evaluation of reports of dead birds may indicate the need for increased testing of birds 
and/or mosquitoes to better assess virus transmission among the bird and mosquito populations 
at particular times throughout the season.  
Most birds that are infected with EEE virus generally survive the viremia, making dead bird EEE 
virus monitoring impractical. MASP does not conduct routine surveillance of EEE in birds for 
public health surveillance purposes because it does not provide additional information useful for 
determining levels of human risk.  Testing of individual bird specimens for EEE infection will be 
determined on an as-needed basis as determined by the MDPH Public Health Veterinarian and 
the MASP.  The MDPH Pubic Health Veterinarian will determine the appropriateness of testing 
specimens from dead bird clusters for both for WNV and EEE infections.   
3. Laboratory Testing of Live Birds: The MASP may capture, bleed and release birds during 
the season to collect supplemental information about virus activity in an area where infections in 
birds are increasing. 
 
C.  Animal Surveillance: West Nile Virus (WNV) and Eastern Equine Encephalitis (EEE) Virus 
 
Testing for WNV and EEE virus: Specimens from horses and other domestic animals that have severe 
neurological disease suspected of being caused by EEE virus or WNV infection are tested at SLI. 
Confirmatory testing, when necessary, may take up to nine working days. Massachusetts’ veterinarians, 
the state Department of Agricultural Resources, USDA and Tufts University School of Veterinary Medicine 
collaborate with the MASP to identify and report suspect animal cases. In addition, blood samples from 
other sources such as zoos, horse stables or wild animals may be tested. Current information on WNV 
and EEE virus infections in horses along with clinical specimen submission procedures are disseminated 
to large animal veterinarians, stable owners, and other populations as needed, through mailings and 
postings on the MDPH Arbovirus website at www.mass.gov/dph. Many horses are immunized against 
infection with WNV and EEE virus with available veterinary vaccines. This is the primary means of 
preventing infection in horses.  
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D. Human Surveillance 
1. Passive surveillance: Specimens from clinical cases of encephalitis and meningo-encephalitis are 
submitted to MDPH and screened for possible causes of infection, including WNV and EEE virus. 
Confirmatory testing, when necessary, may take three to seven working days. Selected cases of other 
human disease, such as aseptic meningitis, may be screened, if appropriate.  Current information on 
WNV and EEE virus infections in humans along with clinical specimen submission procedures are 
disseminated to physicians (infectious disease, emergency medicine and primary care), emergency room 
directors and hospital infection control practitioners through mailings, broadcast faxes, and postings on 
the MDPH Arbovirus website at www.mass.gov/dph.     
2. Active surveillance:  If surveillance data indicate a high risk of human disease, active surveillance 
may be instituted in targeted areas. Active surveillance involves regularly contacting local health care 
facilities to communicate current surveillance information, prevention strategies and specimen submission 
procedures. HHAN (Health and Homeland Alert Network) alerts are sent to local boards of health upon 
confirmation of EEE virus or WNV virus in any specimen; health care facilities are advised of increased 
risk status and the corresponding need to send specimens to SLI for testing. 
3. Pesticide related surveillance: Outreach on pesticide illness reporting will be coordinated by the 
MDPH Bureau of Environmental Health. In the event of an aerial pesticide application, active surveillance 
efforts will be implemented with emergency departments and intensified outreach efforts will be made to 
health care providers. 
 
 
V. Prevention and Control 
 
The MASP will provide information to guide planning and actions to reduce the risk of human disease 
from EEE virus and WNV.  MDPH works to identify and support the use of risk reduction and disease 
prevention methods that are specific to the causes of disease; and supports planning and practices which 
incorporate the most appropriate prevention methods and appropriate use of pesticides.  
 
 
 
Communication of Information  
1. Routine Information:   
 
Prior to the beginning of the Arbovirus season, general disease information and specimen submission 
procedures will be provided to local boards of health via electronic messages from the Massachusetts 
Health and Homeland Alert Network (HHAN). General information and fact sheets are posted on the 
MDPH Arbovirus website and available for Mosquito Control Projects, physicians, veterinarians, animal 
control officers, and other agencies.  
 
 
2. Positive EEE Virus and WNV Findings in Mosquitoes, Birds, Horses (and other Veterinary 
Specimens), and Humans:  
 
Laboratory confirmation of a human WNV or EEE case is immediately reported by telephone to the 
submitting physician, and Local Board of Health (LBOH) in the town where the case resides. If the LBOH 
cannot be reached via telephone in a timely manner, a severe level HHAN alert will be sent.  
 
Laboratory confirmation of a horse (or other veterinary specimen) with WNV or EEE virus infection will be 
immediately reported by telephone to the submitting veterinarian, the Department of Agricultural 
Resources- Bureau of Animal Health, Biosecurity and Dairy Services and the LBOH. As with human 
cases, if the LBOH cannot be reached in a timely manner, a severe level HHAN alert will be sent.  
 
Initial positive findings in birds (WNV) and mosquitoes (WNV and EEE) from a given town will be reported 
to the LBOH by telephone.  Adjacent towns will be notified via a moderate level HHAN alert.  Any 
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additional positive findings in birds or mosquitoes will be reported simultaneously to the town and 
adjacent towns via a moderate level HHAN alert.  
 
At the time of notification, MDPH will encourage local Boards of Health to share the information with other 
local agencies and high-risk populations in their community as appropriate. MDPH provides local Boards 
of Health with sample press releases for their use. Depending on the circumstances, MDPH may also 
issue a public health alert. In addition, weekly summaries of results from avian samples submitted and 
tested will be posted as News Items on the HHAN by town.  
 
All laboratory confirmed results for WNV and EEE virus in humans, horses, other veterinary specimens, 
mosquitoes and birds are provided to the regional health department representative, mosquito control 
projects and members of the State Reclamation and Mosquito Control Board (SRMCB) once the LBOH 
has been notified. 
 
After all appropriate individuals and agencies have been sent notification, positive surveillance findings 
are made available to the media and general public on the MDPH Arbovirus website at 
www.mass.gov/dph. This website, which also includes a variety of educational materials related to 
preventing mosquito-borne diseases, is updated on a daily basis throughout the Arbovirus season. 
Results are also reported to the CDC’s Arbonet reporting system.  
3. Public Health Alerts and Media Advisories: MDPH issues public health alerts through the 
media when surveillance information indicates an increased risk of human disease or if a 
significant surveillance event occurs (for example, the first arbovirus activity of the season). In 
general, alerts will include current surveillance information and emphasize prevention strategies.  
Alerts will be drafted in consultation with outside state and local agencies, as indicated.   
 
VI. Recommendations for a Phased Response to EEE virus and WNV Surveillance Data  
The recommendations provided here are based on current knowledge of risk and 
appropriateness of available interventions to reduce the risk for human disease. Multiple factors 
contribute to the risk of mosquito-transmitted human disease. Decisions on risk reduction 
measures should be made after consideration of all surveillance information for that area at that 
time.  
Recommendations regarding the WNV phased response plan (Table 1) incorporate several 
components presented in the “Massachusetts Surveillance and Response Plan for Mosquito-
Borne Disease”, May 2004, as well as those presented in the CDC document, 
“Epidemic/Epizootic West Nile virus in the United States: Guidelines for Surveillance Prevention, 
and Control”, 3rd Revision, 2003.   
Recommendations regarding the EEE virus phased response plan (Table 2) incorporate 
information provided in the MDPH document, “Vector Control Plan to Prevent Eastern (Equine) 
Encephalitis”, 1991, and results of analyses of additional surveillance data collected in 
Massachusetts since that time. 
Public awareness of what can be done to reduce risk of infection is of utmost importance. The level of 
EEE virus and WNV activity may occasionally present a potential for increased virus transmission to 
humans. Typically, risk is expected to be relatively low, and the routine precautions taken by individuals 
may be sufficient to reduce opportunities for infection. These guidelines take into consideration the 
complexity of reducing risk of human disease from EEE virus and WNV infection and form a framework 
for decision-making.  
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2. Phased response 
General guidelines are provided for an array of situations that are noted in the Surveillance and 
Response Plan Tables that follow. Specific situations must be evaluated individually and options 
discussed before final decisions on specific actions are made. The assessment of risk from mosquito-
borne disease is complex and many factors modify specific risk factors. MDPH works with local public 
health agencies, mosquito control projects, and the SRMCB to develop the most appropriate prevention 
activities to reduce the risk of human disease. There is no single indicator that can provide a precise 
measure of risk, and no single action that can assure prevention of infection. 
 
When recommending the use of mosquito larvicides or adulticide, MDPH works collaboratively with 
SRMCB and with regional mosquito control projects to identify and support the use of safe and effective 
mosquito control measures based on integrated pest management (IPM) principles.  
 
 
A. MDPH Guidance:  
The MDPH Arbovirus Program will determine human risk levels as outlined in the phased response tables 
of this plan. Risk levels are defined for focal areas. “Focal Areas” may incorporate multiple communities, 
towns or cities.  Factors considered in the determination of human risk in a focal area include: mosquito 
habitat, prior isolations, human population densities, timing of recent isolations of virus in mosquitoes, the 
cyclical nature of human outbreaks (EEE), current and predicted weather and seasonal conditions 
needed to present risk of human disease.  
 
If the risk of an outbreak is widespread and covers multiple jurisdictions, MDPH will confer with local 
health agencies, SRMCB, MCP’s, and MAG to discuss the use of intensive mosquito control methods and 
determine whether measures need to be taken by the agencies to allow for and assure that the most 
appropriate mosquito control interventions are applied to reduce risk of human infection. These 
interventions may include state-funded aerial application of mosquito adulticide. Factors to be considered 
in making this decision include the cyclical, seasonal and biological conditions needed to present a 
continuing high risk of WNV or EEE human disease.  
 
Once significant human risk has been identified in a focal area by MDPH, MDPH will coordinate with the 
SRMCB to determine the adulticide activities that should be considered and implemented in response.  
The SRMCB will provide recommendations on appropriate pesticide(s), extent, route and means of 
treatment, and the location of specific treatment areas. 
Based on historical experience with EEE virus, MDPH has identified specific critical indicators for EEE 
virus and provides specific risk reduction and prevention guidance for seasons with an anticipated 
increased EEE risk. 
 
  
  
3.  Risk Reduction and Prevention Guidance for Seasons with Indicators of Increased EEE Risk: 
 
a. MDPH may increase the number of public health alerts throughout the season to remind the public of 
the steps to take to reduce their risk of exposure to mosquitoes. 
 
b. MCP’s may increase their source reduction activities to reduce mosquito-breeding habitats and to 
reduce adult mosquito abundance. This may include ground and aerial larviciding. 
 
c. After sustained findings of positive mosquito isolates, if not already in progress, adult mosquito control 
efforts including targeted ground adulticiding operations should be considered. The decision to use 
ground-based adult mosquito control will depend on critical modifying variables including the time of year, 
mosquito population abundance and proximity of virus activity to at-risk populations.  
 
d. Other intensified efforts may be implemented following coordinated recommendations from MDPH and 
other agencies including DEP, MDAR, and DCR. 
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 Table 1.  Guidelines for Phased Response to WNV Surveillance Data 
 
Risk 
Category 
Probability of 
human outbreak 
Definition of Risk Category for a Focal Area1 
 
Recommended Response  
1 Remote All of the following conditions must be met: 
 
Prior Year 
No prior year WNV activity detected in the focal 
area. 
And 
 
Current Year 
No current surveillance findings indicating WNV 
activity in birds or mosquitoes in the focal area                  
 
       And 
 
No horse or human cases. 
 
 
1. MDPH staff provides educational materials and 
clinical specimen submission protocols to targeted 
groups involved in arbovirus surveillance, including, but 
not limited to, local boards of health, physicians, 
veterinarians, animal control officers, and stable 
owners. 
 
2. Educational efforts directed to the general public on 
personal prevention steps and source reduction, 
particularly to those populations at higher risk for 
severe disease (e.g., the elderly). 
 
3. Routine avian surveillance activities: Dead bird 
reporting and recorded information via MDPH Public 
Health Information Line. 
 
4. Assess mosquito populations, monitor larval and 
adult mosquito density.  
 
5. Routine collection and testing of mosquitoes. 
 
6. Initiate source reduction; use larvicides at specific 
sites identified by entomologic survey. In making a 
decision to use larvicide consider the abundance of 
Culex larvae, intensity of prior virus activity and 
weather. 
 
7.  Locally established, standard, adult mosquito 
control activities are implemented.  No specific 
supplemental control efforts are recommended. 
 
 
8. Passive human and horse surveillance. 
 
9.  Emphasize the need for schools to comply with MA 
requirements for filing outdoor IPM plans. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
1
 Focal Area- May incorporate multiple communities, towns or cities. Factors considered in determination of  
human risk in a focal area include mosquito habitat, prior isolations, human population densities, timing of current 
isolations of virus in mosquitoes, the cyclical and seasonal conditions needed to present risk of human disease  
 
 13 
2 Low Prior Year 
Any WNV activity in birds or mosquitoes in the 
community or focal area 
 
Or 
 
Current Year 
 
Sporadic WNV activity in mosquitoes in the focal 
area. Sporadic activity is defined when 1-2 
isolates are found within 1-2 weeks of routine 
collections; or, one WNV positive bird 
 
And 
 
No horse or human cases  
Response as in category 1, plus:  
  
1. Expand community outreach and public education 
programs, particularly among high-risk populations, 
focused on risk potential and personal protection, 
emphasizing source reduction.   
 
2.  Increase larval control and source reduction 
measures. 
 
3. Public health alert sent out by MDPH in response to 
first WNV virus positive bird and mosquito pool 
detected during the season.  The alert will summarize 
current surveillance information and emphasize 
personal prevention strategies. 
 
4. Locally established standard adult mosquito control 
activities continue. 
 
 
3 Moderate Prior Year                                               
Confirmation of one or more human or horse 
WNV cases; or sustained WNV activity in 
mosquitoes and/ or birds for 2 or more weeks. 
 
Or 
 
Current year                                              
Sustained WNV activity for 2 or more weeks in 
birds* and /or mosquitoes (<15 mosquito isolates 
from routine collections) 
 
* Two confirmed WNV positive birds in a 
community or focal area 
 
And 
 
No horse or human WNV cases                                                                
 
 
Response as in category 2, plus: 
 
1.  Outreach and public health educational efforts are 
intensified including media alerts as needed. 
 
 2. If not already in progress, standard, locally 
established adult mosquito control efforts including 
targeted ground adulticiding operations should be 
considered against Culex mosquitoes and other 
potential vectors, as appropriate.   The decision to use 
ground-based adult mosquito control will depend on 
critical modifying variables including the time of year, 
mosquito population abundance and proximity of virus 
activity to at-risk populations.  
 
3. Duly authorized local officials may request that DPH 
Commissioner issue a certification that pesticide 
application is necessary to protect public health in 
order to preempt homeowner private property no-spray 
requests. 
 
4. Supplemental mosquito trapping and testing may be 
performed in areas with positive WNV findings.  
  
5.  Local boards of health are contacted via phone or 
HHAN (Health and Homeland Alert Network) upon 
confirmation of WNV in any specimen. Advise health 
care facilities of increased risk status and 
corresponding needs to send specimens to SLI for 
testing. 
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4 High Current Year 
 
Sustained or increasing WNV activity in 
mosquitoes with mosquito isolates > 15 from 
routine collections in a community or focal area. 
Sustained elevated minimum infection rates for 
MDPH WNV trap sites 
 
                 And/or 
 
MDPH confirmation of WNV in a horse at any 
time 
 
                  And/or, 
 
MDPH confirmation of WNV in a human at any 
time 
 Response as in category 3, plus:  
 
1. Intensify public education on personal protection 
measures including avoiding outdoor activity during 
peak mosquito hours, wearing appropriate clothing, 
using repellents and source reduction. 
a. Utilize multimedia messages including public health 
alerts from MDPH, press releases from local boards of 
health, local newspaper articles, cable channel 
interviews, etc. 
b.  Encourage local boards of health to actively seek 
out high-risk populations in their communities (nursing 
homes, schools, etc.) and educate them on personal 
protection  
 d.  Advisory information on pesticides provided by 
MDPH Center for Environmental Health.                                                                    
e. Urge towns and schools to consider rescheduling 
outdoor events. 
 
2. Intensify and expand active surveillance for human 
cases. 
   
3. Intensify larviciding and/or adulticiding control 
measures where surveillance indicates human risk. 
Local, ground- based ULV applications of adulticide 
may be repeated as necessary to achieve adequate 
mosquito control. Town or city may request preemption 
of homeowner private property no-spray requests. 
 
4. Local officials should evaluate all quantitative 
indicators including population density and time of year 
and may proceed with focal area aerial adulticiding. 
 
5.  Duly authorized local officials may request that the 
DPH Commissioner issue a certification that pesticide 
application is necessary to protect public health in 
order to preempt homeowner private property no-spray 
requests. 
 
6. MDPH will confer with local health officials, SRMCB 
and Mosquito Control Projects to determine if the risk 
of disease transmission threatens to cause multiple 
human cases and warrants classification as level 5. 
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5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Critical  Current Year 
 
More than 1 confirmed human case in a 
community or focal area 
 
Or 
 
More than 1 confirmed horse case in a 
community or focal area 
 
Multiple quantitative measures indicating critical 
risk of human infection (e.g. early season 
positive surveillance indicators, and sustained  
elevated field mosquito infection rates, and horse 
or mammal cases indicating escalating epizootic 
activity)   
 
 
 
Response as in category 4, plus: 
1.  Continued highly intensified public outreach 
messages on personal protective measures. Frequent 
media updates and intensified community level 
education an outreach efforts. 
 
2. The MDPH Arbovirus Program will determine human 
risk levels as outlined in this plan. If risk of outbreak is 
widespread and covers multiple jurisdictions, MDPH 
will confer with local health agencies, SRMCB and 
Mosquito Control Projects to discuss the use of 
intensive mosquito control methods and determine if 
measures need to be taken by the agencies to allow for 
and assure that the most appropriate mosquito control 
interventions are applied to reduce risk of human 
infection. These interventions may include state-funded 
aerial application of mosquito adulticide. 
 
Factors to be considered in making this decision 
include the cyclical, seasonal and biological conditions 
needed to present a continuing high risk of WNV 
human disease.  
 
Once critical human risk has been identified, the 
SRMCB will determine the adulticide activities that 
should be implemented in response to identified risk by 
making recommendations on: 
 
A. Appropriate pesticide 
B. Extent, route and means of treatment 
C.  Targeted treatment areas  
  
  
3. MDPH Center for Environmental Health (CEH) will 
initiate active surveillance via emergency departments 
and with health care provides only if aerial spraying 
commences. 
 
4. MDPH will designate high-risk areas where it has 
issued a certification that pesticide application is 
necessary to protect public health in order to preempt 
homeowner private property no-spray requests. 
If this becomes necessary, notification will be given to 
the public.  
 
5. MDPH recommends restriction of group outdoor 
activities, during peak mosquito activity hours, in areas 
of intensive virus activity. 
 
6. MDPH will communicate with health care providers 
in the affected area regarding surveillance findings and 
encourage prompt sample submission from all clinically 
suspect cases. 
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Table 2.  Guidelines for Phased Response to EEE virus Surveillance Data 
Risk 
Category 
Probability of 
human outbreak 
Definition of Risk Category for a Focal Area2 
 
Recommended Response 
1 Remote All of the following conditions must be met: 
Prior Year 
No EEE virus activity detected in a community or 
focal area 
 
And 
Current Year 
Sporadic EEE virus activity in mosquitoes after 
August 1.  Virus activity is considered to be 
sporadic when 1-2 isolates in Cs. melanura are 
found within 1-2 weeks of routine collections. 
                And 
No animal or human EEE cases. 
 
 
1. MDPH staff provides educational materials and 
clinical specimen submission protocols to targeted 
groups involved in Arbovirus surveillance, including, 
but not limited to, local boards of health, physicians, 
veterinarians, animal control officers, and stable 
owners. 
 
2. Educational efforts directed to the general public 
on personal prevention steps and source reduction, 
particularly to those populations at higher risk for 
severe disease (e.g., the elderly). 
 
3.  Routine collection and testing of mosquitoes. 
 
4. Assess mosquito populations, monitor larval and 
adult mosquito density.  
 
 
5. Initiate source reduction; use larvicides at specific 
sites identified by entomologic survey and targeted 
at the likely amplifying bridge vector species. In 
making a decision to use larvicide consider the 
prevalence of Culiseta and bridge vector larvae, 
intensity of prior virus activity, and weather.        
 
6.  Locally established, standard, adult mosquito 
control activities are implemented.  No specific 
supplemental control efforts are recommended. 
 
 
7. Passive human and horse surveillance. 
 
8.  Emphasize the need for schools to comply with 
MA requirements for filing outdoor IPM plans. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                         
                                                 
2
 Focal Area- May incorporate multiple communities, towns or cities.  Factors considered in the determination of 
human risk in a focal area include: mosquito habitat, prior isolations, human population densities, timing of current 
isolations of virus in mosquitoes, and the cyclical nature of human EEE outbreaks, current weather and seasonal 
conditions needed to present risk of human disease.  
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2 Low Prior Year 
EEE virus activity in mosquitoes in the prior year 
in the focal area 
 
Or 
 
Current Year 
Sporadic EEE Cs. melanura mosquito activity in 
the community or focal area between July 1-
July31.  Virus activity is considered to be 
sporadic when 1-2 isolates in Cs. melanura are 
found within 1-2 weeks of routine collections 
 
And 
 
No animal or human cases. 
Response as in category 1, plus:  
  
1. Expand community outreach and public education 
programs, particularly among high-risk populations, 
focused on risk potential and personal protection, 
emphasizing source reduction.   
 
2.  Increase larval control and source reduction 
measures. 
 
3. Locally established standard adult mosquito 
control activities continue 
 
4. Public health alert sent out by MDPH in response 
to first EEE mosquito isolate detected during the 
season.  The alert will summarize current 
surveillance information and emphasize personal 
prevention strategies. 
   
 
 
3 Moderate Prior Year                                                                                                                           
Confirmation of one human EEE case in the 
community or focal area; or 1 or more EEE 
horse case(s); or sustained EEE virus activity in 
mosquitoes.  Sustained activity’ is defined as 2 
or more positive isolations found for 2 or more 
weeks. 
 
Or 
  
Current year                                                                                            
No animal or human EEE cases in current year 
 
And 
 
Total EEEV isolates in Cs. melanura found after 
July 1 as a result of routine collections are 
between 10-15 in the community or focal area  
                      
 Or 
 
A single EEEV isolate from mosquitoes likely to 
bite humans (bridge vector species) 
                 
Or 
 
A single EEEV isolate in mosquitoes of any 
species, prior to   July 1. 
 
Response as in category 2, plus:
 
1.  Outreach and public health educational efforts 
are intensified including media alerts as needed. 
 
 2. If not already in progress, standard, locally 
established adult mosquito control efforts including 
targeted ground adulticiding operations should be 
considered. The decision to use ground-based adult 
mosquito control will depend on critical modifying 
variables including the time of year, mosquito 
population abundance and proximity of virus activity 
to at-risk populations.  
 
3. Duly authorized local officials may request that the 
DPH Commissioner issue a certification that 
pesticide application is necessary to protect public 
health in order to preempt homeowner private 
property no-spray requests. 
 
4. Supplemental mosquito trapping and testing in 
areas with positive EEEV findings.  Notify all boards 
of health of positive findings.   
 
5. Public health alert sent out by MDPH in response 
to first pool of EEE virus positive mammal-biting 
mosquitoes detected during the season.  The alert 
will summarize current surveillance information and 
emphasize personal prevention strategies. 
6.  HHAN (Health and Homeland Alert Network) 
alerts or phone calls are provided to local boards of 
health upon confirmation of EEE virus in any 
specimen; advise health care facilities of increased 
risk status and corresponding needs to send 
specimens to SLI for testing. 
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4 High Current Year 
 
Total EEEV mosquito isolates numbering more 
than 15 from routine collections with sustained 
or increasing activity in the community or focal 
area. Sustained elevated weekly mosquito 
minimum infection rates.  Virus activity is 
considered to be sustained when isolates are 
found for 2 or more consecutive weeks. 
 
And/or 
 
Isolation of EEEV in more than 1 pool of bridge 
vector mosquitoes 
 
And/or 
 
Confirmation of EEE in an animal at any time 
 
And/or 
 
Confirmation of EEE in a human at any time 
 
Response as in category 3, plus:  
 
1. Intensify public education on personal protection 
measures including avoiding outdoor activity during 
peak mosquito hours, wearing appropriate clothing, 
using repellents and source reduction. 
a. Utilize multimedia messages including public 
health alerts from MDPH, press releases from local 
boards of health, local newspaper articles, cable 
channel interviews, etc. 
b.  Encourage local boards of health to actively seek 
out high-risk populations in their communities 
(nursing homes, schools, workers employed in 
outdoor occupations, etc.) and educate them on 
personal protection  
 d.  Advisory information on pesticides provided by 
MDPH Center for Environmental Health.                                                                    
e. Urge towns and schools to consider rescheduling 
outdoor events. 
   
2. Intensify larviciding and/or adulticiding control 
measures where surveillance indicates human risk. 
Local, ground- based ULV applications of adulticide 
may be repeated as necessary to achieve adequate 
mosquito control. Town or city may request 
preemption of homeowner private property no-spray 
requests. 
 
3.  Active surveillance for human cases is intensified. 
Health care facilities are advised of increased risk 
status and corresponding needs to send specimens 
to SLI for testing. 
4. Local officials should evaluate all quantitative 
indicators including population density and time of 
year and may proceed with focal area aerial 
adulticiding. 
 
5. Duly authorized local officials may request that the 
DPH Commissioner issue a certification that 
pesticide application is necessary to protect public 
health in order to preempt homeowner private 
property no-spray requests. 
 
6. MDPH will confer with local health officials, 
SRMCB and Mosquito Control Projects to determine 
if the risk of disease transmission threatens to cause 
multiple human cases and warrants classification as 
level 5. 
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5 Critical Current Year 
 
More than 1 confirmed human EEE case  
 
Or 
 
Multiple EEE animal cases 
 
Or 
 
Multiple quantitative measures indicating critical 
risk of human infection (e.g. early season 
positive surveillance indicators, and sustained  
high mosquito infection rates, and horse or 
mammal case indicating escalating epizootic 
activity)   
 
 
 
  
Response as in category 4, plus: 
1.  Continued highly intensified public outreach 
messages on personal protective measures. 
Frequent media updates and intensified community 
level education an outreach efforts. 
 
2. The MDPH Arbovirus Program will determine 
human risk levels as outlined in this plan. If risk of 
outbreak is widespread and covers multiple 
jurisdictions, MDPH will confer with local health 
agencies, SRMCB and Mosquito Control Projects to 
discuss the use of intensive mosquito control 
methods and determine the measures needed to be 
taken by the agencies to allow for and assure that 
the most appropriate mosquito control interventions 
are applied to reduce risk of human infection. These 
interventions may include state-funded aerial 
application of mosquito adulticide. 
 
Factors to be considered in making this decision 
include the cyclical, seasonal and biological 
conditions needed to present a continuing high risk 
of EEE human disease.  
 
Once critical human risk has been identified, the 
SRMCB will determine the adulticide activities that 
should be implemented in response to identified risk 
by making recommendations on: 
 
A. Appropriate pesticide 
B. Extent, route and means of treatment 
C.  Targeted treatment areas  
  
  
3. MDPH Center for Environmental Health (CEH) will 
initiate active surveillance via emergency 
departments and with health care provides only if 
aerial spraying commences. 
 
4.  MDPH will designate high-risk areas where 
individual no spray requests may be preempted by 
local and state officials based on this risk level.  If 
this becomes necessary, notification will be given to 
the public.  
 
5. MDPH recommends restriction of group outdoor 
activities, during peak mosquito activity hours, in 
areas of intensive virus activity. 
 
6. MDPH will communicate with health care 
providers in the affected area regarding surveillance 
findings and encourage prompt sample submission 
from all clinically suspect cases. 
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Appendix 1:  Mosquitoes Associated with Arboviral Activity in Massachusetts 
 
Aedes vexans – Is a common nuisance mosquito. Temporary flooded areas such as woodland pools and 
natural depressions are the preferred larval habitat of this mosquito. It feeds on mammals and is a fierce 
human biter. This species is typically collected from May to October. Ae vexans is an epizootic vector of 
Eastern Equine Encephalitis (EEE) Virus. 
 
Coquillettidia perturbans - Cattail marshes are the primary larval habitat of this mosquito. It feeds on 
both birds and mammals. It is a persistent human biter and one of the most common mosquitoes in 
Massachusetts. This species is typically collected from June to September. Cq perturbans is an epizootic 
vector of EEE Virus. 
 
Culex pipiens – Artificial containers are the preferred larval habitat of this mosquito. It feeds mainly on 
birds and occasionally on mammals. It will bite humans, typically from dusk into the evening. This species 
is regularly collected from May to October but can be found year round as it readily overwinters in man-
made structures. Cx pipiens has been implicated as a vector of West Nile Virus (WNV). 
 
Culex restuans – Natural and artificial containers are the preferred larval habitat of this mosquito. It 
feeds almost primarily on birds but has been known to bite humans on occasion. This species is typically 
collected from May to October but can be found year round as it readily overwinters in man-made 
structures.  Cx restuans has been implicated as a vector of WNV.   
 
Culex salinarius – Brackish and freshwater wetlands are the preferred habitat of this mosquito. It feeds 
on birds, mammals, and amphibians and is well known for biting humans. This species is typically 
collected from May to October but can be found year round as it readily overwinters in natural and man-
made structures. Cx salinarius may be involved in the transmission of both WNV and EEE virus.   
 
Culiseta melanura –White Cedar and Red Maple swamps are the preferred larval habitat of this 
mosquito. It feeds almost exclusively on birds. This species is typically collected from May to October. Cs 
melanura is the primary enzootic vector of EEE virus.  
 
Ochlerotatus canadensis – Shaded woodland pools are the preferred larval habitat of this mosquito. It 
feeds mainly on birds and mammals but is also known to take blood meals from amphibians and reptiles. 
This mosquito can be a fierce human biter near it larval habitat. This species is typically collected from 
May to October. Oc canadensis is an epizootic vector of EEE virus. 
 
Ochlerotatus japonicus – Natural and artificial containers such as tires, catch basins, and rock pools are 
the preferred larval habitat of this mosquito. It feeds mainly on mammals and is a fierce human biter. This 
species is typically collected from May to October. Oc japonicus may be involved in the transmission of 
both WNV and EEE virus. 
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Figure 1:  Location of MDPH EEE virus Mosquito Trap Sites 
 
 
 
 
 
 
 
 
 
